WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Altimmune earnings were -$87.7M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ALT earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$22.1M, up 13.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ALT reported annual earnings of -$95.1M, with 7.5% growth. The next ALT earnings date is Nov 11, 2025.

ALT earnings history

Current Revenue
$15.0k
Current Earnings
-$87.7M
Current Profit Margin
-584,973.3%

ALT Return on Equity

Current Company
-62.6%
Current Industry
-10%
Current Market
30.7%
ALT's Return on Equity (-62.6%)... subscribe to Premium to read more.
High Return on Equity Performance

ALT undefined

Current Company
-55.3%
Current Industry
-0.2%
ALT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ALT announces earnings.

ALT undefined

Current Company
-48.67%
Current Industry
6.4%
ALT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ALT-$88.03M-$87.75MN/A-$1.18
TVRD-$13.45M-$20.89MN/A-$16.18
FDMT-$189.02M-$196.14MN/A-$3.53
TECX-$62.41M-$65.98MN/A-$2.87
LCTX-$40.28M-$40.91MN/A-$0.18
View Top Biotech Stocks

ALT earnings dates

Next earnings date
Nov 11, 2025

Altimmune Earnings Reports & History FAQ

What were Altimmune's earnings last quarter?

On ALT's earnings call on Invalid Date, Altimmune (NASDAQ: ALT) reported Q2 2025 earnings per share (EPS) of -$0.27, up 22.86% year over year. Total ALT earnings for the quarter were -$22.15 million. In the same quarter last year, Altimmune's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Altimmune stock.

When does Altimmune report earnings?

The next ALT earnings call is Invalid Date. Add ALT to your watchlist to be reminded of Altimmune's next earnings date.

Is Altimmune profitable or losing money?

As of the last Altimmune earnings report, Altimmune is currently losing money. Altimmune's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$87.75 million, a 13.42% decrease year over year.

What was ALT's earnings growth in the past year?

As of Altimmune's earnings date in Invalid Date, Altimmune's earnings has grown year over year. ALT earnings in the past year totalled -$87.75 million.

What are Altimmune's earnings expectations?

The current EPS estimate for Altimmune's earnings report in Invalid Date is -$0.27.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.